Most recently, IL-22 demonstrated pro-tumoral activity in human pancreatic cancer cell line via inducing the expression of vascular endothelial growth factor (VEGF) and anti-apoptotic factor Bcl-XL[46]. This evidence concerns the gene VEGFA and familial pancreatic carcinoma.